BAH vs CNH

The Advanced Deterministic Scorecard reveals a mixed financial profile for BAH, with a weak Piotroski F-Score of 4/9 indicating marginal financial health, and no available Altman Z-Score to assess distress risk. Despite strong historical ROE of 75.2% and solid cash flow generation, the company faces significant headwinds with declining revenue and earnings, reflected in negative YoY growth of -8.1% and -52.9%, respectively. Valuation metrics suggest the stock is trading above its Graham Number of $35.57 and growth-based intrinsic value of $49.0, yet at a discount to sector peers on P/E. Analysts have a consensus 'hold' rating with a target price of $102.91, nearly at current levels, while technical trend signals remain bearish.

CNH presents a conflicting profile: a strong Piotroski F-Score of 7/9 indicates solid operational health, yet the stock is plagued by a severe earnings collapse (-50.10% YoY) and a completely bearish technical trend (0/100). While the PEG ratio of 0.60 suggests significant undervaluation relative to growth potential, the current price of $10.25 trades at a premium to the Graham Number ($7.58) and the growth-based intrinsic value ($2.87). The disconnect between bullish analyst targets ($13.88) and the consistent multi-year price decline suggests a value trap risk despite strong short-term liquidity.